Related Experiment Video
Updated: May 7, 2025

06:16
The Miniature Pig: A Large Animal Model for Cochlear Implant Research
Published on: July 28, 2022
2.7K
Animal models of cochlear implant: Classification and update
Haiqiao Du1,2,3,4, Jianan Li1,2,3,4, Wei Chen1,2,3,4
1Department of Otolaryngology-Head & Neck Surgery, The Sixth Medical Center of PLA General Hospital, Beijing, China.
Journal of Otology
|December 30, 2024
Summary
Cochlear implantation (CI) is a leading treatment for deafness, but tissue responses like inflammation can hinder outcomes. This review examines animal models to advance CI research and improve patient results.
Area of Science:
- Biomedical Engineering
- Otolaryngology
- Neuroscience
Background:
- Cochlear implantation (CI) is the most effective treatment for severe to profound sensorineural deafness.
- CI technology has advanced significantly, expanding applications and improving surgical techniques.
- Adverse tissue responses in the cochlea, including inflammation and fibrosis, can negatively impact CI outcomes.
Purpose of the Study:
- To review existing animal models for cochlear implantation research.
- To highlight advancements in CI research utilizing these models.
- To identify future research directions for improving CI efficacy.
Main Methods:
- Systematic review of literature on animal models for cochlear implantation.
- Analysis of research advancements and challenges in the field.
- Identification of key areas for future investigation.
Main Results:
- Animal models are crucial for preclinical research in cochlear implantation.
- Understanding tissue responses in animal models can inform therapeutic strategies.
- Current research focuses on mitigating adverse tissue reactions and optimizing implant performance.
Conclusions:
- Further research using refined animal models is essential for advancing cochlear implantation.
- Developing targeted therapies to manage cochlear tissue responses is critical.
- Future studies should focus on translating preclinical findings into improved clinical outcomes for CI patients.

